InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,099.96
(
1.02%
)
US TECH 100
17,244.00
(
1.57%
)
Dow Jones
38,239.66
(
0.40%
)
Brent Oil
88.17
(
0.00%
)
Bitcoin
63,062.72
(
-1.06%
)
Post# of 14684
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Solar_Express

Send PM Follow Ignore
Followers 73
Posts 10908
Boards Moderated 1
Alias Born 10/02/2009

Solar_Express

Re: Itchy palm post# 11860

Saturday, 03/28/2020 3:27:35 PM

Saturday, March 28, 2020 3:27:35 PM

Post# of 14684
Authors Comment
Thomas Barnard
Comments174 | + Follow
Author’s reply »
Leronlimab may be useful for extreme cases with the cytokine storms, but many of us older folks are hoping that companies like Generex (GNBT) will stay the course because the epidemiologists say this disease is now out in the general population from here forward. Generex's Ii-key technology may be one of the best for vaccine development, which could save us from catching one of these horrible cases.

https://seekingalpha.com/article/4334730-cytodyn-may-be-one-of-first-biotechs-to-drug-helps-against-covidminus-19
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up